PFIZER INC 4

Pfizer Chairman & CEO Albert Bourla received 84 phantom stock units tied to Pfizer common stock as deferred compensation under a company plan.

On July 9, 2026, Pfizer Inc. Chairman & CEO Albert Bourla acquired 84 phantom stock units under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan at a reference price of approximately $24.25 per unit, representing deferred compensation units that track the value of Pfizer common stock but are settled in cash following his separation from service. Each phantom unit corresponds economically to one share of Pfizer common stock, bringing his total deferred phantom stock holdings under this plan to 772,938 units, an estimated value of about $18.75 million based on the current stock price. This transaction reflects a routine, plan-based accrual of deferred compensation rather than an open-market purchase or sale of common equity.

Filing Facts

CIK

78003

Ticker

PFE

Form

4

Source Type

fda

Accession

0001225208-26-006587

Alert Tier

5